Adma Biologics (ADMA) Revenue (2011 - 2025)
Adma Biologics posted quarterly Revenue of $139.2 million for Q4 2025, up 18.39% year-on-year from $117.5 million in Q4 2024, and up 3.68% on a QoQ basis from $134.2 million in Q3 2025.
Adma Biologics (ADMA) has 14 years of Revenue data on file, last reported at $139.2 million in Q4 2025.
- For the quarter ending Q4 2025, Revenue rose 18.39% year-over-year to $139.2 million; the trailing twelve-month figure through Dec 2025 stood at $510.2 million (up 19.63% YoY), and the FY2025 full-year result was $510.2 million, up 19.63% from the prior year.
- Revenue for Q4 2025 stood at $139.2 million, up from $134.2 million in the prior quarter.
- Across five years, Revenue topped out at $139.2 million in Q4 2025 and bottomed at $16.0 million in Q1 2021.
- The 5-year median for Revenue is $74.5 million (2022), against an average of $77.1 million.
- The widest annual swing landed in 2022, when Revenue surged 320.63%; it then declined 19.84% in 2023.
- A 5-year view of Revenue shows it stood at $55.0 million in 2021, then fell by 9.12% to $50.0 million in 2022, then soared by 47.86% to $73.9 million in 2023, then jumped by 59.06% to $117.5 million in 2024, then climbed by 18.39% to $139.2 million in 2025.
- The last three Revenue figures came in at $139.2 million (Q4 2025), $134.2 million (Q3 2025), and $122.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 306.30 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 2.99 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.61 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.17 Bn |
| 10 | Adma Biologics | 1.90 Bn | 1.81 Bn | 88.82 Mn | 139.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 139.16 Mn |
| Sep 30, 2025 | 134.22 Mn |
| Jun 30, 2025 | 121.98 Mn |
| Mar 31, 2025 | 114.80 Mn |
| Dec 31, 2024 | 117.55 Mn |
| Sep 30, 2024 | 119.84 Mn |
| Jun 30, 2024 | 107.19 Mn |
| Mar 31, 2024 | 81.88 Mn |
| Dec 31, 2023 | 73.90 Mn |
| Sep 30, 2023 | 110.00 Mn |
| Jun 30, 2023 | 60.12 Mn |
| Mar 31, 2023 | 56.91 Mn |
| Dec 31, 2022 | 49.98 Mn |
| Sep 30, 2022 | 41.09 Mn |
| Jun 30, 2022 | 75.00 Mn |
| Mar 31, 2022 | 29.10 Mn |
| Dec 31, 2021 | 55.00 Mn |
| Sep 30, 2021 | 20.68 Mn |
| Jun 30, 2021 | 17.83 Mn |
| Mar 31, 2021 | 16.05 Mn |
| Dec 31, 2020 | 13.96 Mn |
| Sep 30, 2020 | 10.28 Mn |
| Jun 30, 2020 | 7.79 Mn |
| Mar 31, 2020 | 10.20 Mn |
| Dec 31, 2019 | 12.04 Mn |
| Sep 30, 2019 | 7.22 Mn |
| Jun 30, 2019 | 7.00 Mn |
| Mar 31, 2019 | 3.53 Mn |
| Dec 31, 2018 | 4.06 Mn |
| Sep 30, 2018 | 4.23 Mn |
| Jun 30, 2018 | 4.66 Mn |
| Mar 31, 2018 | 4.04 Mn |
| Dec 31, 2017 | 12.00 Mn |
| Sep 30, 2017 | 4.73 Mn |
| Jun 30, 2017 | 3.40 Mn |
| Mar 31, 2017 | 2.63 Mn |
| Dec 31, 2016 | 3.33 Mn |
| Sep 30, 2016 | 2.94 Mn |
| Jun 30, 2016 | 2.27 Mn |
| Mar 31, 2016 | 2.12 Mn |
| Dec 31, 2015 | 4.53 Mn |
| Mar 31, 2013 | 792,935.00 |
| Dec 31, 2012 | 523,284.00 |
| Sep 30, 2012 | 360,338.00 |
| Jun 30, 2012 | 230,096.00 |
| Mar 31, 2012 | 4,400.00 |
| Dec 31, 2011 | 761,042.00 |